ADIM
NBP

Alpha DNA Investment Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Alpha DNA Investment Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-64
Closed -$3K – 352
2021
Q1 		$3K Buy
+64
New +$3.47K ﹤0.01% 480

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alpha DNA Investment Management's NBP Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2021, closing a stake of 64 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in NBP in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 136 funds tracked by Wall St. Rank hold NBP as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 64 NovaBridge Biosciences American Depositary Shares shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's NovaBridge Biosciences American Depositary Shares position peaked at $3K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.